Steve Chapin

Steve Chapin is a Senior Director in Preclinical Development with over 18 years of experience in drug discovery and leadership in the biotech sector. Previously, they held key roles at various organizations, including Bolt Biotherapeutics, Inc., where they revolutionized the cancer immunotherapy discovery process. Steve has an extensive technical background in molecular biology and protein therapeutics, with notable accomplishments in antibody generation and biochemistry. They earned a B.A. in Biology from the University of California, Santa Cruz, and a Ph.D. in Cell Biology from UCLA. Currently, they are the Senior Director at Hinge Bio.